Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Trading Update

19 Jun 2025 07:00

RNS Number : 4709N
Rosslyn Data Technologies PLC
19 June 2025
 

19 June 2025

 

Rosslyn Data Technologies plc

("Rosslyn" or the "Company")

 

Trading Update

Rosslyn to report strong growth for FY 2025 in line with market expectations

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based spend intelligence platform, is pleased to provide the following update on trading for the year ended 30 April 2025 ("FY 2025") and the Company's outlook.

 

In line with market expectations and the Company's last trading update that was announced on 5 March 2025, the Company expects to report revenue growth for FY 2025 of c. 14% to £3.3m (FY 2024: £2.9m) and a significant improvement in adjusted EBITDA loss to £1.7m (FY 2024: £2.5m loss). Furthermore, the Company had cash and cash equivalents of c. £1.7m as at 30 April 2025 (30 April 2024: £0.6m), with cash burn rate significantly reduced to £142k per month (FY 2024: £218k).

 

The increase in revenue in FY 2025 reflects the contribution from development fees and also growth in professional services fees, the latter being for work undertaken to tailor the Company's solution to align with customers' infrastructure or meet specific additional solution requirements. Development fees are for additional bespoke development performed for the Company's major new client (the "Major New Client") that was won during the first half of FY 2025 and is a leading global technology company and household name.

 

The improvement in adjusted EBITDA reflects the increased contribution to revenue from professional services and development fees as well as the strategic decision to prioritise quality of revenues and not renew certain low-value or low-margin contracts. It also reflects a reduction in operating expenses due to lower employee-related costs following a restructuring in the prior year and lower rent costs following the closure of the Company's Portsmouth office.

 

The Company entered the current financial year to 30 April 2026 ("FY 2026") experiencing increased momentum compared with the same time in the prior year, and with a larger total and weighted pipeline. Rosslyn is in advanced negotiations with a number of potential new and existing customers regarding new contracts and is pleased to have already secured a three-year contract, worth £200k of revenue over the term of the contract, with a British train operating company, which is a new customer. With the expected conversion of the Company's pipeline as well as further planned development work for the Major New Client, the Company expects its monthly cash burn rate to be further reduced significantly over the course of the first half of FY 2026 and for it to become cash generative on a monthly basis by the end of FY 2026.

 

As previously announced, the Board has been prioritising sustainable growth, and it continues to do so. One of the outcomes from prioritising quality of revenues has been the Company's pipeline including customer profiles that are moving up the size spectrum. Commensurate with this, the timeline for conversion of some of these opportunities has taken longer than initially anticipated, including the rollout to other departments of the Major New Customer, and this is expected to continue into FY 2026.

 

Notwithstanding the impact on the Company's short-term growth rate, the Board believes that this approach will enable Rosslyn to generate maximum value for shareholders in the medium- to long-term. Accordingly, and with the Company having a clear path to delivering positive and sustainable growth for FY 2026, the Board looks to the future with confidence.

 

The Company will provide further detail in its full year results announcement.

 

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

++44 (0)20 4582 3500

 

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend intelligence and predictive analytics platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKFBDFBKDQAD
Date   Source Headline
23rd Mar 20215:54 pmRNSExercise of Options
4th Mar 20217:00 amRNSChange of auditor
12th Jan 20217:00 amRNSHalf-year Report
21st Dec 20207:00 amRNSLaunch of CustomsCloudTM product
11th Nov 20207:00 amRNSContract Win
29th Oct 20204:45 pmRNSResult of AGM
30th Sep 20209:20 amRNSNotice of AGM
29th Sep 202010:15 amRNSHolding(s) in Company
28th Sep 20204:33 pmRNSChange of Registered Office
25th Sep 202012:01 pmRNSIssue of Equity
24th Sep 20207:00 amRNSDirector/PDMR Dealing
22nd Sep 20207:00 amRNSAudited Results for the year ended 30 April 2020
1st Sep 20207:00 amRNSBoard Update
28th Aug 20204:42 pmRNSHolding(s) in Company
17th Aug 20207:00 amRNSAppointment of Chief Customer Officer
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:01 amRNSPrice Monitoring Extension
7th Jul 20207:00 amRNSStrengthening client relationships during COVID-19
25th Jun 20207:00 amRNSContract Renewals
16th Jun 20209:01 amRNSDirector/PDMR Options
15th Jun 20207:00 amRNSGrant of Options
12th Jun 20204:13 pmRNSHolding(s) in Company
11th Jun 20203:07 pmRNSHolding(s) in Company
9th Jun 20208:40 amRNSHolding(s) in Company
2nd Jun 20208:07 amRNSHolding(s) in Company
1st Jun 20208:56 amRNSHolding(s) in Company
29th May 20209:43 amRNSHolding(s) in Company
29th May 20208:43 amRNSHolding(s) in Company
28th May 202012:32 pmRNSHolding(s) in Company
28th May 202010:39 amRNSHolding(s) in Company
27th May 202012:06 pmRNSResult of General Meeting
19th May 20208:19 amRNSHolding(s) in Company
18th May 20202:48 pmRNSHolding(s) in Company
15th May 20202:49 pmRNSHolding(s) in Company
7th May 20203:53 pmRNSPlacing to Raise £7.3m and Trading Update
10th Feb 202010:56 amRNSDirector/PDMR Shareholding
4th Feb 20205:26 pmRNSDirector/PDMR Shareholding
15th Jan 20209:17 amRNSPDMR Shareholding
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
14th Jan 20207:01 amRNSContract Win
14th Jan 20207:00 amRNSHalf-year Report
8th Jan 20207:00 amRNSContract Wins
11th Dec 20197:00 amRNSTrading Update
26th Nov 20198:57 amRNSHolding(s) in Company
25th Nov 20196:17 pmRNSDirector/PDMR Shareholding
17th Oct 20192:01 pmRNSResult of AGM
17th Oct 20197:00 amRNSBoard Changes
24th Sep 20197:00 amRNSAcquisition
17th Sep 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.